- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Kalaris Therapeutics (KLRS)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 42.89 mm | 42.89 mm | 42.89 mm | 42.89 mm | 42.89 mm | 42.89 mm |
| Cash burn (monthly) | 15.35 mm | (no burn) | 4.25 mm | 4.68 mm | 3.78 mm | 7.18 mm |
| Cash used (since last report) | 35.19 mm | n/a | 9.74 mm | 10.74 mm | 8.66 mm | 16.47 mm |
| Cash remaining | 7.69 mm | n/a | 33.15 mm | 32.15 mm | 34.22 mm | 26.41 mm |
| Runway (months of cash) | 0.5 | n/a | 7.8 | 6.9 | 9.1 | 3.7 |
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Nov 25 | Matthew Gall | Stock Option Common Stock | Grant | Acquire A | No | No | 4.99 | 235,000 | 1.17 mm | 235,000 |
| 10 Apr 25 | Hallal David | Stock Option Common Stock | Grant | Acquire A | No | No | 7.31 | 18,000 | 131.58 k | 18,000 |
| 10 Apr 25 | Matthew Feinsod | Stock Option Common Stock | Grant | Acquire A | No | No | 7.31 | 101,000 | 738.31 k | 101,000 |
| 10 Apr 25 | Matthew Feinsod | Stock Option Common Stock | Grant | Acquire A | No | No | 7.31 | 70,551 | 515.73 k | 70,551 |
| 10 Apr 25 | Patterson Leone D | Stock Option Common Stock | Grant | Acquire A | No | No | 7.31 | 18,000 | 131.58 k | 18,000 |